Keith A. Betts, PhD

home / authors / keith-a-betts-phd

Articles

September 5th 2024

Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes

Keith A. Betts, PhD Nikolaus G. Oberprieler, PhD, MSc, MBA Aozhou Wu, PhD Glen James, PhD Scott Beeman, PharmD Alain Gay, MD Xuanhao He, PhD David Vizcaya, PhD, MPH

This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.

August 16th 2022

Geographical Variation in Kidney Function Testing and Associations With Health Care Costs Among Patients With Chronic Kidney Disease and Type 2 Diabetes

Keith A. Betts, PhD Jinlin Song, PhD Jay Elliott, PhD Neil Warnock, MD, MS, CHCQM Ryan Farej, BS Aozhou Wu, PhD Rakesh Singh, PhD

December 8th 2021

Medical Costs for Managing Chronic Kidney Disease and Related Complications in Patients With Chronic Kidney Disease and Type 2 Diabetes

Keith A. Betts, PhD Jinlin Song, PhD Elizabeth Faust, MBA, MPH Karen Yang, BA Yuxian Du, PhD Sheldon X. Kong, PhD Rakesh Singh, PhD

September 17th 2014

Impact of Atypical Antipsychotic Use Among Adolescents With Attention-Deficit/Hyperactivity Disorder

Vanja Sikirica, PharmD, MPH Steven R. Pliszka, MD Keith A. Betts, PhD Paul Hodgkins, PhD, MSc Thomas M. Samuelson, BA Jipan Xie, MD, PhD M. Haim Erder, PhD Ryan S. Dammerman, MD, PhD Brigitte Robertson, MD Eric Q. Wu, PhD

A retrospective study of the treatment patterns and economic outcomes associated with off-label atypical antipsychotic use in the treatment of adolescents with attention-deficit/hyperactivity disorder.